Actively Recruiting

All Genders
ID06240559

In-vivo Treatment Verification for HDR Brachytherapy Patients Using an External Imaging Panel

Led by Maastricht Radiation Oncology · Updated on 2025-05-09

100

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

This research aims to collect data during High Dose Rate (HDR) brachytherapy treatments to track the brachytherapy source inside patients. The goal is to verify that the treatment plan is being delivered accurately and to detect errors or motion that are not currently monitored. The study involves patients receiving HDR brachytherapy for gynecologic (endometrium/cervix) or prostate cancer, treated on a CT couch. An external imaging panel (the investigational product) will be positioned beside the treatment table to continuously acquire data throughout the treatment. This device will not touch the patient or change the clinical workflow, as it is placed at a safe distance and powered by two cables integrated neatly with the treatment table setup. The data collected will be compared against the planned treatment information to identify discrepancies and improve treatment verification. Participants will undergo their usual HDR brachytherapy treatment while the external panel collects data automatically during radiation exposure. Clinical staff will not need to perform additional actions. The data analysis will be done offline after treatment sessions to avoid interruptions. The primary outcomes measured are dwell times and dwell positions during treatment within one year. The total participation duration depends on the patient's treatment schedule.

CONDITIONS

Brief Title

In Vivo Treatment Verification of Brachytherapy

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Treatment site Gynaecology (Endometrium/Cervix) and prostate
  • Treatment: HDR Brachytherapy
  • Patient will be treated on CT Couch
  • Mentally competent patient
Not Eligible

You will not qualify if you...

  • Incapacitated patient

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Implementation

Duration - Duration of HDR brachytherapy treatment

Participants undergo HDR brachytherapy treatment with an external imaging panel placed on the side of the treatment table to acquire data during the treatment. The panel does not contact the participant and does not affect the clinical workflow.

Visits coincide with treatment sessions

Long-term Monitoring

Duration - 1 year

Data analysis is performed offline to assess dwell times and dwell positions over the course of one year following treatment.

No additional visits required for participants

Trial Site Locations

Total: 1 location

1

Maastro

Maastricht, Limburg, Netherlands, 6229 ET

Actively Recruiting

Loading map...

Research Team

J

Janneke Waelen

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

A Phase II Clinical Trial Evaluating Safety and Efficacy of ...

Sarcoma,Soft Tissue

Actively Recruiting

1 location

MRI/PET PSMA-Based Study of Salvage HDR Brachytherapy and Ex...

Prostate Cancer

Actively Recruiting

1 location

PRO-BOOST-N: Prostate-First Versus Combined Prostate and Nod...

Prostate Cancer

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here